Cargando…
Myostatin: a Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients
Myotubular myopathy, also called X-linked centronuclear myopathy (XL-CNM), is a severe congenital disease targeted for therapeutic trials. To date, biomarkers to monitor disease progression and therapy efficacy are lacking. The Mtm1(−/y) mouse is a faithful model for XL-CNM, due to myotubularin 1 (M...
Autores principales: | Koch, Catherine, Buono, Suzie, Menuet, Alexia, Robé, Anne, Djeddi, Sarah, Kretz, Christine, Gomez-Oca, Raquel, Depla, Marion, Monseur, Arnaud, Thielemans, Leen, Servais, Laurent, Laporte, Jocelyn, Cowling, Belinda S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267729/ https://www.ncbi.nlm.nih.gov/pubmed/32514412 http://dx.doi.org/10.1016/j.omtm.2020.04.022 |
Ejemplares similares
-
Natural history study and statistical modeling of disease progression in a preclinical model of myotubular myopathy
por: Buono, Suzie, et al.
Publicado: (2022) -
Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances
por: Gómez-Oca, Raquel, et al.
Publicado: (2021) -
Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice
por: Tasfaout, Hichem, et al.
Publicado: (2017) -
Centronuclear (myotubular) myopathy
por: Jungbluth, Heinz, et al.
Publicado: (2008) -
Extensive morphological and immunohistochemical characterization in myotubular myopathy
por: Shichiji, Minobu, et al.
Publicado: (2013)